You are currently viewing a new version of our website. To view the old version click .

Women’s Special Issue Series: Breast Imaging—Update and New Approaches toward Diagnosis and Treatment

This special issue belongs to the section “Medical Imaging and Theranostics“.

Special Issue Information

Dear Colleagues,

Breast cancer is the cause of most female cancer deaths in the Western world, with early detection of cancer being pivotal for improved prognosis and survival. Imaging plays a key role in breast cancer detection and staging, and helps guiding treatment decisions. Currently established breast-imaging modalities comprise mammography, digital breast tomosynthesis (DBT), ultrasound, contrast-enhanced mammography (CEM), and magnetic resonance imaging (MRI). With recent significant advances in techniques and data analysis, such as the possibility to enhance medical imaging, other modalities are in active development and evaluation. This Special Issue of Diagnostics with a focus on “Breast Imaging: update and new approaches toward diagnosis and treatment” invites submissions relating to recent advances, current possibilities and emerging techniques in breast imaging. We welcome submissions from all authors, irrespective of gender.

Prof. Dr. Katja Pinker-Domenig
Dr. Masako Kataoka
Guest Editors

Women’s Special Issue Series

This Special Issue is part of Diagnostics's Women’s Special Issue Series, hosted by women editors for women researchers. The Series advocates the advancement of women in science. We invite contributions to the Special Issue whose lead authors identify as women. The submission of articles with all-women authorship is especially encouraged. However, we do welcome articles from all authors, irrespective of gender.

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Diagnostics - ISSN 2075-4418